﻿<?xml version="1.0" encoding="utf-8"?>
<Return xmlns="http://www.irs.gov/efile" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.irs.gov/efile" returnVersion="2014v5.0">
  <ReturnHeader binaryAttachmentCnt="0">
    <ReturnTs>2015-06-30T13:49:53-05:00</ReturnTs>
    <TaxPeriodEndDt>2014-12-31</TaxPeriodEndDt>
    <PreparerFirmGrp>
      <PreparerFirmEIN>560747981</PreparerFirmEIN>
      <PreparerFirmName>
        <BusinessNameLine1Txt>DIXON HUGHES GOODMAN LLP</BusinessNameLine1Txt>
      </PreparerFirmName>
      <PreparerUSAddress>
        <AddressLine1Txt>500 RIDGEFIELD COURT</AddressLine1Txt>
        <CityNm>ASHEVILLE</CityNm>
        <StateAbbreviationCd>NC</StateAbbreviationCd>
        <ZIPCd>28806</ZIPCd>
      </PreparerUSAddress>
    </PreparerFirmGrp>
    <ReturnTypeCd>990</ReturnTypeCd>
    <TaxPeriodBeginDt>2014-01-01</TaxPeriodBeginDt>
    <Filer>
      <EIN>203692587</EIN>
      <BusinessName>
        <BusinessNameLine1Txt>THE HAMNER INSTITUTES FOR HEALTH SCIENCE</BusinessNameLine1Txt>
      </BusinessName>
      <BusinessNameControlTxt>HAMN</BusinessNameControlTxt>
      <PhoneNum>9195581255</PhoneNum>
      <USAddress>
        <AddressLine1Txt>PO BOX 12137</AddressLine1Txt>
        <CityNm>RESEARCH TRIANGLE PARK</CityNm>
        <StateAbbreviationCd>NC</StateAbbreviationCd>
        <ZIPCd>277092137</ZIPCd>
      </USAddress>
    </Filer>
    <BusinessOfficerGrp>
      <PersonNm>WILLIAM F GREENLEE</PersonNm>
      <PersonTitleTxt>PRESIDENT &amp; CEO</PersonTitleTxt>
      <PhoneNum>9195581255</PhoneNum>
      <SignatureDt>2015-06-30</SignatureDt>
      <DiscussWithPaidPreparerInd>1</DiscussWithPaidPreparerInd>
    </BusinessOfficerGrp>
    <PreparerPersonGrp>
      <PreparerPersonNm>AMY BIBBY</PreparerPersonNm>
      <PTIN>P00445891</PTIN>
      <PhoneNum>8282542254</PhoneNum>
    </PreparerPersonGrp>
    <TaxYr>2014</TaxYr>
    <BuildTS>2016-04-25 22:37:26Z</BuildTS>
  </ReturnHeader>
  <ReturnData documentCnt="9">
    <IRS990 documentId="RetDoc1038000001" referenceDocumentId="RetDoc1044400001">
      <DoingBusinessAsName>
        <BusinessNameLine1Txt>INSTITUTES FOR LIFE SCIENCE</BusinessNameLine1Txt>
      </DoingBusinessAsName>
      <PrincipalOfficerNm>WILLIAM F GREENLEE</PrincipalOfficerNm>
      <USAddress>
        <AddressLine1Txt>PO BOX 12137</AddressLine1Txt>
        <CityNm>RESEARCH TRIANGLE PARK</CityNm>
        <StateAbbreviationCd>NC</StateAbbreviationCd>
        <ZIPCd>277092137</ZIPCd>
      </USAddress>
      <GrossReceiptsAmt>15232998</GrossReceiptsAmt>
      <GroupReturnForAffiliatesInd>0</GroupReturnForAffiliatesInd>
      <Organization501c3Ind>X</Organization501c3Ind>
      <WebsiteAddressTxt>WWW.THEHAMNER.ORG</WebsiteAddressTxt>
      <TypeOfOrganizationCorpInd>X</TypeOfOrganizationCorpInd>
      <FormationYr>1977</FormationYr>
      <LegalDomicileStateCd>NC</LegalDomicileStateCd>
      <ActivityOrMissionDesc>TO ACCELERATE TRANSLATION AND COMMERCIALIZATION OF INNOVATIVE LIFE SCIENCE AND BIOMEDICAL RESEARCH</ActivityOrMissionDesc>
      <VotingMembersGoverningBodyCnt>9</VotingMembersGoverningBodyCnt>
      <VotingMembersIndependentCnt>7</VotingMembersIndependentCnt>
      <TotalEmployeeCnt>86</TotalEmployeeCnt>
      <TotalVolunteersCnt>8</TotalVolunteersCnt>
      <TotalGrossUBIAmt>0</TotalGrossUBIAmt>
      <NetUnrelatedBusTxblIncmAmt>0</NetUnrelatedBusTxblIncmAmt>
      <PYContributionsGrantsAmt>12245077</PYContributionsGrantsAmt>
      <CYContributionsGrantsAmt>13303070</CYContributionsGrantsAmt>
      <PYProgramServiceRevenueAmt>239000</PYProgramServiceRevenueAmt>
      <CYProgramServiceRevenueAmt>215507</CYProgramServiceRevenueAmt>
      <PYInvestmentIncomeAmt>1728481</PYInvestmentIncomeAmt>
      <CYInvestmentIncomeAmt>1423800</CYInvestmentIncomeAmt>
      <PYOtherRevenueAmt>136879</PYOtherRevenueAmt>
      <CYOtherRevenueAmt>290621</CYOtherRevenueAmt>
      <PYTotalRevenueAmt>14349437</PYTotalRevenueAmt>
      <CYTotalRevenueAmt>15232998</CYTotalRevenueAmt>
      <PYGrantsAndSimilarPaidAmt>15175</PYGrantsAndSimilarPaidAmt>
      <CYGrantsAndSimilarPaidAmt>10960</CYGrantsAndSimilarPaidAmt>
      <PYBenefitsPaidToMembersAmt>0</PYBenefitsPaidToMembersAmt>
      <CYBenefitsPaidToMembersAmt>0</CYBenefitsPaidToMembersAmt>
      <PYSalariesCompEmpBnftPaidAmt>7253221</PYSalariesCompEmpBnftPaidAmt>
      <CYSalariesCompEmpBnftPaidAmt>7337256</CYSalariesCompEmpBnftPaidAmt>
      <PYTotalProfFndrsngExpnsAmt>0</PYTotalProfFndrsngExpnsAmt>
      <CYTotalProfFndrsngExpnsAmt>549000</CYTotalProfFndrsngExpnsAmt>
      <CYTotalFundraisingExpenseAmt>549000</CYTotalFundraisingExpenseAmt>
      <PYOtherExpensesAmt>8026736</PYOtherExpensesAmt>
      <CYOtherExpensesAmt>9361779</CYOtherExpensesAmt>
      <PYTotalExpensesAmt>15295132</PYTotalExpensesAmt>
      <CYTotalExpensesAmt>17258995</CYTotalExpensesAmt>
      <PYRevenuesLessExpensesAmt>-945695</PYRevenuesLessExpensesAmt>
      <CYRevenuesLessExpensesAmt>-2025997</CYRevenuesLessExpensesAmt>
      <TotalAssetsBOYAmt>15998681</TotalAssetsBOYAmt>
      <TotalAssetsEOYAmt>17606318</TotalAssetsEOYAmt>
      <TotalLiabilitiesBOYAmt>10121789</TotalLiabilitiesBOYAmt>
      <TotalLiabilitiesEOYAmt>13755423</TotalLiabilitiesEOYAmt>
      <NetAssetsOrFundBalancesBOYAmt>5876892</NetAssetsOrFundBalancesBOYAmt>
      <NetAssetsOrFundBalancesEOYAmt>3850895</NetAssetsOrFundBalancesEOYAmt>
      <InfoInScheduleOPartIIIInd>X</InfoInScheduleOPartIIIInd>
      <MissionDesc>TO ACCELERATE TRANSLATION AND COMMERCIALIZATION OF INNOVATIVE LIFE SCIENCE AND BIOMEDICAL RESEARCH THROUGH THE DEVELOPMENT AND INTEGRATION OF CUTTING-EDGE SAFETY SCIENCE PREDICTIVE TECHNOLOGIES.WE AIM TO ACHIEVE THIS BY:-FOSTERING PARTNERSHIPS WITH ACADEMIA, INDUSTRY, AND GOVERNMENT-PERFORMING CUTTING-EDGE RESEARCH TO ADVANCE THE SCIENCE OF CHEMICAL AND DRUG SAFETY-ACCELERATING DEVELOPMENT OF NEW, SAFER MEDICINES</MissionDesc>
      <SignificantNewProgramSrvcInd>0</SignificantNewProgramSrvcInd>
      <SignificantChangeInd>0</SignificantChangeInd>
      <ExpenseAmt>13253790</ExpenseAmt>
      <GrantAmt>10960</GrantAmt>
      <RevenueAmt>424487</RevenueAmt>
      <Desc>PLEASE SEE SCHEDULE O FOR A FULL DESCRIPTION.</Desc>
      <TotalProgramServiceExpensesAmt>13253790</TotalProgramServiceExpensesAmt>
      <DescribedInSection501c3Ind referenceDocumentId="RetDoc1039100001">1</DescribedInSection501c3Ind>
      <ScheduleBRequiredInd referenceDocumentId="RetDoc1234500001">1</ScheduleBRequiredInd>
      <PoliticalCampaignActyInd>0</PoliticalCampaignActyInd>
      <LobbyingActivitiesInd>0</LobbyingActivitiesInd>
      <SubjectToProxyTaxInd>0</SubjectToProxyTaxInd>
      <DonorAdvisedFundInd referenceDocumentId="RetDoc1040000001">0</DonorAdvisedFundInd>
      <ConservationEasementsInd referenceDocumentId="RetDoc1040000001">0</ConservationEasementsInd>
      <CollectionsOfArtInd referenceDocumentId="RetDoc1040000001">0</CollectionsOfArtInd>
      <CreditCounselingInd referenceDocumentId="RetDoc1040000001">0</CreditCounselingInd>
      <TempOrPermanentEndowmentsInd referenceDocumentId="RetDoc1040000001">0</TempOrPermanentEndowmentsInd>
      <ReportLandBuildingEquipmentInd referenceDocumentId="RetDoc1040000001">1</ReportLandBuildingEquipmentInd>
      <ReportInvestmentsOtherSecInd referenceDocumentId="RetDoc1040000001">1</ReportInvestmentsOtherSecInd>
      <ReportProgramRelatedInvstInd referenceDocumentId="RetDoc1040000001">0</ReportProgramRelatedInvstInd>
      <ReportOtherAssetsInd referenceDocumentId="RetDoc1040000001">0</ReportOtherAssetsInd>
      <ReportOtherLiabilitiesInd referenceDocumentId="RetDoc1040000001">1</ReportOtherLiabilitiesInd>
      <IncludeFIN48FootnoteInd referenceDocumentId="RetDoc1040000001">1</IncludeFIN48FootnoteInd>
      <IndependentAuditFinclStmtInd referenceDocumentId="RetDoc1040000001">0</IndependentAuditFinclStmtInd>
      <ConsolidatedAuditFinclStmtInd referenceDocumentId="RetDoc1040000001">1</ConsolidatedAuditFinclStmtInd>
      <SchoolOperatingInd>0</SchoolOperatingInd>
      <ForeignOfficeInd>0</ForeignOfficeInd>
      <ForeignActivitiesInd>0</ForeignActivitiesInd>
      <MoreThan5000KToOrgInd>0</MoreThan5000KToOrgInd>
      <MoreThan5000KToIndividualsInd>0</MoreThan5000KToIndividualsInd>
      <ProfessionalFundraisingInd referenceDocumentId="RetDoc1041200001">1</ProfessionalFundraisingInd>
      <FundraisingActivitiesInd referenceDocumentId="RetDoc1041200001">0</FundraisingActivitiesInd>
      <GamingActivitiesInd referenceDocumentId="RetDoc1041200001">0</GamingActivitiesInd>
      <OperateHospitalInd>0</OperateHospitalInd>
      <GrantsToOrganizationsInd>0</GrantsToOrganizationsInd>
      <GrantsToIndividualsInd>0</GrantsToIndividualsInd>
      <ScheduleJRequiredInd referenceDocumentId="RetDoc1042400001">1</ScheduleJRequiredInd>
      <TaxExemptBondsInd>0</TaxExemptBondsInd>
      <EngagedInExcessBenefitTransInd referenceDocumentId="RetDoc1042800001">0</EngagedInExcessBenefitTransInd>
      <PYExcessBenefitTransInd referenceDocumentId="RetDoc1042800001">0</PYExcessBenefitTransInd>
      <LoanOutstandingInd referenceDocumentId="RetDoc1042800001">0</LoanOutstandingInd>
      <GrantToRelatedPersonInd referenceDocumentId="RetDoc1042800001">0</GrantToRelatedPersonInd>
      <BusinessRlnWithOrgMemInd referenceDocumentId="RetDoc1042800001">0</BusinessRlnWithOrgMemInd>
      <BusinessRlnWithFamMemInd referenceDocumentId="RetDoc1042800001">0</BusinessRlnWithFamMemInd>
      <BusinessRlnWithOfficerEntInd referenceDocumentId="RetDoc1042800001">1</BusinessRlnWithOfficerEntInd>
      <DeductibleNonCashContriInd>0</DeductibleNonCashContriInd>
      <DeductibleArtContributionInd>0</DeductibleArtContributionInd>
      <TerminateOperationsInd>0</TerminateOperationsInd>
      <PartialLiquidationInd>0</PartialLiquidationInd>
      <DisregardedEntityInd referenceDocumentId="RetDoc1043400001">0</DisregardedEntityInd>
      <RelatedEntityInd referenceDocumentId="RetDoc1043400001">1</RelatedEntityInd>
      <RelatedOrganizationCtrlEntInd>1</RelatedOrganizationCtrlEntInd>
      <TransactionWithControlEntInd referenceDocumentId="RetDoc1043400001">0</TransactionWithControlEntInd>
      <TrnsfrExmptNonChrtblRltdOrgInd referenceDocumentId="RetDoc1043400001">0</TrnsfrExmptNonChrtblRltdOrgInd>
      <ActivitiesConductedPrtshpInd referenceDocumentId="RetDoc1043400001">0</ActivitiesConductedPrtshpInd>
      <ScheduleORequiredInd>1</ScheduleORequiredInd>
      <IRPDocumentCnt>15</IRPDocumentCnt>
      <IRPDocumentW2GCnt>0</IRPDocumentW2GCnt>
      <BackupWthldComplianceInd>1</BackupWthldComplianceInd>
      <EmployeeCnt>86</EmployeeCnt>
      <EmploymentTaxReturnsFiledInd>1</EmploymentTaxReturnsFiledInd>
      <UnrelatedBusIncmOverLimitInd>0</UnrelatedBusIncmOverLimitInd>
      <ForeignFinancialAccountInd>0</ForeignFinancialAccountInd>
      <ProhibitedTaxShelterTransInd>0</ProhibitedTaxShelterTransInd>
      <TaxablePartyNotificationInd>0</TaxablePartyNotificationInd>
      <NondeductibleContributionsInd>0</NondeductibleContributionsInd>
      <QuidProQuoContributionsInd>0</QuidProQuoContributionsInd>
      <Form8282PropertyDisposedOfInd>0</Form8282PropertyDisposedOfInd>
      <RcvFndsToPayPrsnlBnftCntrctInd>0</RcvFndsToPayPrsnlBnftCntrctInd>
      <PayPremiumsPrsnlBnftCntrctInd>0</PayPremiumsPrsnlBnftCntrctInd>
      <IndoorTanningServicesInd>0</IndoorTanningServicesInd>
      <InfoInScheduleOPartVIInd>X</InfoInScheduleOPartVIInd>
      <GoverningBodyVotingMembersCnt>9</GoverningBodyVotingMembersCnt>
      <IndependentVotingMemberCnt>7</IndependentVotingMemberCnt>
      <FamilyOrBusinessRlnInd>0</FamilyOrBusinessRlnInd>
      <DelegationOfMgmtDutiesInd>0</DelegationOfMgmtDutiesInd>
      <ChangeToOrgDocumentsInd>0</ChangeToOrgDocumentsInd>
      <MaterialDiversionOrMisuseInd>0</MaterialDiversionOrMisuseInd>
      <MembersOrStockholdersInd>0</MembersOrStockholdersInd>
      <ElectionOfBoardMembersInd>0</ElectionOfBoardMembersInd>
      <DecisionsSubjectToApprovaInd>0</DecisionsSubjectToApprovaInd>
      <MinutesOfGoverningBodyInd>1</MinutesOfGoverningBodyInd>
      <MinutesOfCommitteesInd>1</MinutesOfCommitteesInd>
      <OfficerMailingAddressInd>0</OfficerMailingAddressInd>
      <LocalChaptersInd>0</LocalChaptersInd>
      <Form990ProvidedToGvrnBodyInd>1</Form990ProvidedToGvrnBodyInd>
      <ConflictOfInterestPolicyInd>1</ConflictOfInterestPolicyInd>
      <AnnualDisclosureCoveredPrsnInd>1</AnnualDisclosureCoveredPrsnInd>
      <RegularMonitoringEnfrcInd>1</RegularMonitoringEnfrcInd>
      <WhistleblowerPolicyInd>1</WhistleblowerPolicyInd>
      <DocumentRetentionPolicyInd>1</DocumentRetentionPolicyInd>
      <CompensationProcessCEOInd>1</CompensationProcessCEOInd>
      <CompensationProcessOtherInd>1</CompensationProcessOtherInd>
      <InvestmentInJointVentureInd>0</InvestmentInJointVentureInd>
      <StatesWhereCopyOfReturnIsFldCd>NC</StatesWhereCopyOfReturnIsFldCd>
      <OtherWebsiteInd>X</OtherWebsiteInd>
      <UponRequestInd>X</UponRequestInd>
      <BooksInCareOfDetail>
        <BusinessName>
          <BusinessNameLine1Txt>JAMIE H WILKERSON</BusinessNameLine1Txt>
        </BusinessName>
        <PhoneNum>9195581255</PhoneNum>
        <USAddress>
          <AddressLine1Txt>6 DAVIS DRIVE</AddressLine1Txt>
          <CityNm>RESEARCH TRIANGLE PARK</CityNm>
          <StateAbbreviationCd>NC</StateAbbreviationCd>
          <ZIPCd>27709</ZIPCd>
        </USAddress>
      </BooksInCareOfDetail>
      <Form990PartVIISectionAGrp>
        <PersonNm>DR JOHN G DENT</PersonNm>
        <TitleTxt>CHAIRMAN</TitleTxt>
        <AverageHoursPerWeekRt>10.00</AverageHoursPerWeekRt>
        <AverageHoursPerWeekRltdOrgRt>1.00</AverageHoursPerWeekRltdOrgRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <OfficerInd>X</OfficerInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>DR CHARLES E HAMNER JR</PersonNm>
        <TitleTxt>VICE CHAIR</TitleTxt>
        <AverageHoursPerWeekRt>5.00</AverageHoursPerWeekRt>
        <AverageHoursPerWeekRltdOrgRt>1.00</AverageHoursPerWeekRltdOrgRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <OfficerInd>X</OfficerInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>DR ROBERT W RICKARD</PersonNm>
        <TitleTxt>TREASURER</TitleTxt>
        <AverageHoursPerWeekRt>1.00</AverageHoursPerWeekRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <OfficerInd>X</OfficerInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>DR GARHENG KONG</PersonNm>
        <TitleTxt>BOARD MEMBER</TitleTxt>
        <AverageHoursPerWeekRt>1.00</AverageHoursPerWeekRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>DR JOSEPH S PAGANO</PersonNm>
        <TitleTxt>SECRETARY</TitleTxt>
        <AverageHoursPerWeekRt>1.00</AverageHoursPerWeekRt>
        <AverageHoursPerWeekRltdOrgRt>1.00</AverageHoursPerWeekRltdOrgRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <OfficerInd>X</OfficerInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>MR ROBERT EUBANKS</PersonNm>
        <TitleTxt>BOARD MEMBER</TitleTxt>
        <AverageHoursPerWeekRt>1.00</AverageHoursPerWeekRt>
        <AverageHoursPerWeekRltdOrgRt>1.00</AverageHoursPerWeekRltdOrgRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>DR EDWARD CARNEY</PersonNm>
        <TitleTxt>BOARD MEMBER</TitleTxt>
        <AverageHoursPerWeekRt>1.00</AverageHoursPerWeekRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>MR JOEL MARCUS</PersonNm>
        <TitleTxt>BOARD MEMBER</TitleTxt>
        <AverageHoursPerWeekRt>1.00</AverageHoursPerWeekRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>DR WILLIAM F GREENLEE</PersonNm>
        <TitleTxt>PRESIDENT &amp; CEO</TitleTxt>
        <AverageHoursPerWeekRt>60.00</AverageHoursPerWeekRt>
        <AverageHoursPerWeekRltdOrgRt>1.00</AverageHoursPerWeekRltdOrgRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <OfficerInd>X</OfficerInd>
        <ReportableCompFromOrgAmt>508295</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>32314</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>MS JAMIE WILKERSON</PersonNm>
        <TitleTxt>EXECUTIVE DIRECTOR OF FINANCE</TitleTxt>
        <AverageHoursPerWeekRt>50.00</AverageHoursPerWeekRt>
        <OfficerInd>X</OfficerInd>
        <ReportableCompFromOrgAmt>188040</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>14913</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>DR MELVIN ANDERSEN</PersonNm>
        <TitleTxt>CHIEF SCIENTIFIC OFFICER</TitleTxt>
        <AverageHoursPerWeekRt>50.00</AverageHoursPerWeekRt>
        <KeyEmployeeInd>X</KeyEmployeeInd>
        <ReportableCompFromOrgAmt>316652</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>23416</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>DR HARVEY CLEWELL III</PersonNm>
        <TitleTxt>DIRECTOR, CHHA</TitleTxt>
        <AverageHoursPerWeekRt>50.00</AverageHoursPerWeekRt>
        <HighestCompensatedEmployeeInd>X</HighestCompensatedEmployeeInd>
        <ReportableCompFromOrgAmt>182920</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>23330</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>DR MORRIS BUD NELSON</PersonNm>
        <TitleTxt>IN-HOUSE COUNSEL</TitleTxt>
        <AverageHoursPerWeekRt>50.00</AverageHoursPerWeekRt>
        <HighestCompensatedEmployeeInd>X</HighestCompensatedEmployeeInd>
        <ReportableCompFromOrgAmt>167721</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>16792</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>DR DAROL DODD</PersonNm>
        <TitleTxt>SENIOR RESEARCH TOX.</TitleTxt>
        <AverageHoursPerWeekRt>50.00</AverageHoursPerWeekRt>
        <HighestCompensatedEmployeeInd>X</HighestCompensatedEmployeeInd>
        <ReportableCompFromOrgAmt>160010</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>18999</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>DR EDWARD LECLUYSE</PersonNm>
        <TitleTxt>ASSOCIATE INVESTIGATOR</TitleTxt>
        <AverageHoursPerWeekRt>50.00</AverageHoursPerWeekRt>
        <HighestCompensatedEmployeeInd>X</HighestCompensatedEmployeeInd>
        <ReportableCompFromOrgAmt>151501</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>16871</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>DR REBECCA CLEWELL</PersonNm>
        <TitleTxt>SENIOR INVESTIGATOR &amp; ASSOC. DIR.</TitleTxt>
        <AverageHoursPerWeekRt>50.00</AverageHoursPerWeekRt>
        <HighestCompensatedEmployeeInd>X</HighestCompensatedEmployeeInd>
        <ReportableCompFromOrgAmt>117412</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>11897</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <TotalReportableCompFromOrgAmt>1792551</TotalReportableCompFromOrgAmt>
      <TotReportableCompRltdOrgAmt>0</TotReportableCompRltdOrgAmt>
      <TotalOtherCompensationAmt>158532</TotalOtherCompensationAmt>
      <IndivRcvdGreaterThan100KCnt>12</IndivRcvdGreaterThan100KCnt>
      <FormerOfcrEmployeesListedInd>0</FormerOfcrEmployeesListedInd>
      <TotalCompGreaterThan150KInd>1</TotalCompGreaterThan150KInd>
      <CompensationFromOtherSrcsInd>0</CompensationFromOtherSrcsInd>
      <ContractorCompensationGrp>
        <ContractorName>
          <BusinessName>
            <BusinessNameLine1Txt>MISPRO BIOTECH</BusinessNameLine1Txt>
          </BusinessName>
        </ContractorName>
        <ContractorAddress>
          <USAddress>
            <AddressLine1Txt>450 EAST 29TH ST STE 602</AddressLine1Txt>
            <CityNm>NEW YORK</CityNm>
            <StateAbbreviationCd>NY</StateAbbreviationCd>
            <ZIPCd>10016</ZIPCd>
          </USAddress>
        </ContractorAddress>
        <ServicesDesc>RESEARCH SERVICES</ServicesDesc>
        <CompensationAmt>592768</CompensationAmt>
      </ContractorCompensationGrp>
      <ContractorCompensationGrp>
        <ContractorName>
          <BusinessName>
            <BusinessNameLine1Txt>CAIN GLOBAL PARTNERS</BusinessNameLine1Txt>
          </BusinessName>
        </ContractorName>
        <ContractorAddress>
          <USAddress>
            <AddressLine1Txt>3014 FAIRVIEW RD</AddressLine1Txt>
            <CityNm>RALEIGH</CityNm>
            <StateAbbreviationCd>NC</StateAbbreviationCd>
            <ZIPCd>27608</ZIPCd>
          </USAddress>
        </ContractorAddress>
        <ServicesDesc>CONSULTING</ServicesDesc>
        <CompensationAmt>549272</CompensationAmt>
      </ContractorCompensationGrp>
      <ContractorCompensationGrp>
        <ContractorName>
          <BusinessName>
            <BusinessNameLine1Txt>TECHNOLOGY ASSOCIATES</BusinessNameLine1Txt>
          </BusinessName>
        </ContractorName>
        <ContractorAddress>
          <USAddress>
            <AddressLine1Txt>3434 KILDAIRE FARM ROAD SUITE 390</AddressLine1Txt>
            <CityNm>CARY</CityNm>
            <StateAbbreviationCd>NC</StateAbbreviationCd>
            <ZIPCd>27518</ZIPCd>
          </USAddress>
        </ContractorAddress>
        <ServicesDesc>INFORMATION TECHNOLOGY</ServicesDesc>
        <CompensationAmt>231644</CompensationAmt>
      </ContractorCompensationGrp>
      <ContractorCompensationGrp>
        <ContractorName>
          <BusinessName>
            <BusinessNameLine1Txt>SCOTTINGTON QUINCY SILER</BusinessNameLine1Txt>
          </BusinessName>
        </ContractorName>
        <ContractorAddress>
          <USAddress>
            <AddressLine1Txt>3514 ARCADIAN COURT</AddressLine1Txt>
            <CityNm>CASTRO VALLEY</CityNm>
            <StateAbbreviationCd>CA</StateAbbreviationCd>
            <ZIPCd>94546</ZIPCd>
          </USAddress>
        </ContractorAddress>
        <ServicesDesc>CONSULTING</ServicesDesc>
        <CompensationAmt>176335</CompensationAmt>
      </ContractorCompensationGrp>
      <ContractorCompensationGrp>
        <ContractorName>
          <BusinessName>
            <BusinessNameLine1Txt>LISL SHODA</BusinessNameLine1Txt>
          </BusinessName>
        </ContractorName>
        <ContractorAddress>
          <USAddress>
            <AddressLine1Txt>276 MARMONA DRIVE</AddressLine1Txt>
            <CityNm>MENLO PARK</CityNm>
            <StateAbbreviationCd>CA</StateAbbreviationCd>
            <ZIPCd>94025</ZIPCd>
          </USAddress>
        </ContractorAddress>
        <ServicesDesc>CONSULTING</ServicesDesc>
        <CompensationAmt>158065</CompensationAmt>
      </ContractorCompensationGrp>
      <CntrctRcvdGreaterThan100KCnt>5</CntrctRcvdGreaterThan100KCnt>
      <GovernmentGrantsAmt>1145433</GovernmentGrantsAmt>
      <AllOtherContributionsAmt>12157637</AllOtherContributionsAmt>
      <TotalContributionsAmt>13303070</TotalContributionsAmt>
      <ProgramServiceRevenueGrp>
        <Desc>RESEARCH PROJECT</Desc>
        <BusinessCd>541900</BusinessCd>
        <TotalRevenueColumnAmt>190266</TotalRevenueColumnAmt>
        <RelatedOrExemptFuncIncomeAmt>190266</RelatedOrExemptFuncIncomeAmt>
      </ProgramServiceRevenueGrp>
      <ProgramServiceRevenueGrp>
        <Desc>EDUCATION COURSE</Desc>
        <BusinessCd>541900</BusinessCd>
        <TotalRevenueColumnAmt>25241</TotalRevenueColumnAmt>
        <RelatedOrExemptFuncIncomeAmt>25241</RelatedOrExemptFuncIncomeAmt>
      </ProgramServiceRevenueGrp>
      <TotalProgramServiceRevenueAmt>215507</TotalProgramServiceRevenueAmt>
      <InvestmentIncomeGrp>
        <TotalRevenueColumnAmt>506380</TotalRevenueColumnAmt>
        <ExclusionAmt>506380</ExclusionAmt>
      </InvestmentIncomeGrp>
      <GrossRentsGrp>
        <RealAmt>208980</RealAmt>
      </GrossRentsGrp>
      <LessRentalExpensesGrp>
        <RealAmt>0</RealAmt>
      </LessRentalExpensesGrp>
      <RentalIncomeOrLossGrp>
        <RealAmt>208980</RealAmt>
      </RentalIncomeOrLossGrp>
      <NetRentalIncomeOrLossGrp>
        <TotalRevenueColumnAmt>208980</TotalRevenueColumnAmt>
        <RelatedOrExemptFuncIncomeAmt>208980</RelatedOrExemptFuncIncomeAmt>
      </NetRentalIncomeOrLossGrp>
      <GrossAmountSalesAssetsGrp>
        <OtherAmt>917420</OtherAmt>
      </GrossAmountSalesAssetsGrp>
      <LessCostOthBasisSalesExpnssGrp>
        <OtherAmt>0</OtherAmt>
      </LessCostOthBasisSalesExpnssGrp>
      <GainOrLossGrp>
        <OtherAmt>917420</OtherAmt>
      </GainOrLossGrp>
      <NetGainOrLossInvestmentsGrp>
        <TotalRevenueColumnAmt>917420</TotalRevenueColumnAmt>
        <ExclusionAmt>917420</ExclusionAmt>
      </NetGainOrLossInvestmentsGrp>
      <OtherRevenueMiscGrp>
        <Desc>MISCELLANEOUS REVENUE</Desc>
        <BusinessCd>900099</BusinessCd>
        <TotalRevenueColumnAmt>81641</TotalRevenueColumnAmt>
        <ExclusionAmt>81641</ExclusionAmt>
      </OtherRevenueMiscGrp>
      <OtherRevenueTotalAmt>81641</OtherRevenueTotalAmt>
      <TotalRevenueGrp>
        <TotalRevenueColumnAmt>15232998</TotalRevenueColumnAmt>
        <RelatedOrExemptFuncIncomeAmt>424487</RelatedOrExemptFuncIncomeAmt>
        <UnrelatedBusinessRevenueAmt>0</UnrelatedBusinessRevenueAmt>
        <ExclusionAmt>1505441</ExclusionAmt>
      </TotalRevenueGrp>
      <GrantsToDomesticOrgsGrp>
        <TotalAmt>10960</TotalAmt>
        <ProgramServicesAmt>10960</ProgramServicesAmt>
      </GrantsToDomesticOrgsGrp>
      <CompCurrentOfcrDirectorsGrp>
        <TotalAmt>880677</TotalAmt>
        <ProgramServicesAmt>306061</ProgramServicesAmt>
        <ManagementAndGeneralAmt>574616</ManagementAndGeneralAmt>
      </CompCurrentOfcrDirectorsGrp>
      <OtherSalariesAndWagesGrp>
        <TotalAmt>5137189</TotalAmt>
        <ProgramServicesAmt>4054599</ProgramServicesAmt>
        <ManagementAndGeneralAmt>1082590</ManagementAndGeneralAmt>
      </OtherSalariesAndWagesGrp>
      <PensionPlanContributionsGrp>
        <TotalAmt>387614</TotalAmt>
        <ProgramServicesAmt>159922</ProgramServicesAmt>
        <ManagementAndGeneralAmt>227692</ManagementAndGeneralAmt>
      </PensionPlanContributionsGrp>
      <OtherEmployeeBenefitsGrp>
        <TotalAmt>534195</TotalAmt>
        <ProgramServicesAmt>348592</ProgramServicesAmt>
        <ManagementAndGeneralAmt>185603</ManagementAndGeneralAmt>
      </OtherEmployeeBenefitsGrp>
      <PayrollTaxesGrp>
        <TotalAmt>397581</TotalAmt>
        <ProgramServicesAmt>292535</ProgramServicesAmt>
        <ManagementAndGeneralAmt>105046</ManagementAndGeneralAmt>
      </PayrollTaxesGrp>
      <FeesForServicesLegalGrp>
        <TotalAmt>199738</TotalAmt>
        <ProgramServicesAmt>18259</ProgramServicesAmt>
        <ManagementAndGeneralAmt>181479</ManagementAndGeneralAmt>
      </FeesForServicesLegalGrp>
      <FeesForServicesAccountingGrp>
        <TotalAmt>55591</TotalAmt>
        <ManagementAndGeneralAmt>55591</ManagementAndGeneralAmt>
      </FeesForServicesAccountingGrp>
      <FeesForServicesProfFundraising>
        <TotalAmt>549000</TotalAmt>
        <FundraisingAmt>549000</FundraisingAmt>
      </FeesForServicesProfFundraising>
      <FeesForServicesOtherGrp>
        <TotalAmt>1555626</TotalAmt>
        <ProgramServicesAmt>1139618</ProgramServicesAmt>
        <ManagementAndGeneralAmt>416008</ManagementAndGeneralAmt>
      </FeesForServicesOtherGrp>
      <AdvertisingGrp>
        <TotalAmt>1952</TotalAmt>
        <ManagementAndGeneralAmt>1952</ManagementAndGeneralAmt>
      </AdvertisingGrp>
      <OfficeExpensesGrp>
        <TotalAmt>377020</TotalAmt>
        <ProgramServicesAmt>192121</ProgramServicesAmt>
        <ManagementAndGeneralAmt>184899</ManagementAndGeneralAmt>
      </OfficeExpensesGrp>
      <InformationTechnologyGrp>
        <TotalAmt>315884</TotalAmt>
        <ProgramServicesAmt>169236</ProgramServicesAmt>
        <ManagementAndGeneralAmt>146648</ManagementAndGeneralAmt>
      </InformationTechnologyGrp>
      <OccupancyGrp>
        <TotalAmt>2277273</TotalAmt>
        <ProgramServicesAmt>2277273</ProgramServicesAmt>
      </OccupancyGrp>
      <TravelGrp>
        <TotalAmt>225759</TotalAmt>
        <ProgramServicesAmt>158855</ProgramServicesAmt>
        <ManagementAndGeneralAmt>66904</ManagementAndGeneralAmt>
      </TravelGrp>
      <ConferencesMeetingsGrp>
        <TotalAmt>132650</TotalAmt>
        <ProgramServicesAmt>64885</ProgramServicesAmt>
        <ManagementAndGeneralAmt>67765</ManagementAndGeneralAmt>
      </ConferencesMeetingsGrp>
      <InterestGrp>
        <TotalAmt>53915</TotalAmt>
        <ProgramServicesAmt>53915</ProgramServicesAmt>
      </InterestGrp>
      <DepreciationDepletionGrp>
        <TotalAmt>586823</TotalAmt>
        <ProgramServicesAmt>586823</ProgramServicesAmt>
      </DepreciationDepletionGrp>
      <InsuranceGrp>
        <TotalAmt>159412</TotalAmt>
        <ManagementAndGeneralAmt>159412</ManagementAndGeneralAmt>
      </InsuranceGrp>
      <OtherExpensesGrp>
        <Desc>LAB EXPENSES</Desc>
        <TotalAmt>1624179</TotalAmt>
        <ProgramServicesAmt>1624179</ProgramServicesAmt>
      </OtherExpensesGrp>
      <OtherExpensesGrp>
        <Desc>LAB SUPPLIES</Desc>
        <TotalAmt>1231860</TotalAmt>
        <ProgramServicesAmt>1231860</ProgramServicesAmt>
      </OtherExpensesGrp>
      <OtherExpensesGrp>
        <Desc>EQUIPMENT RENTAL/REPAIR</Desc>
        <TotalAmt>546018</TotalAmt>
        <ProgramServicesAmt>546018</ProgramServicesAmt>
      </OtherExpensesGrp>
      <OtherExpensesGrp>
        <Desc>MISCELLANEOUS</Desc>
        <TotalAmt>18079</TotalAmt>
        <ProgramServicesAmt>18079</ProgramServicesAmt>
      </OtherExpensesGrp>
      <TotalFunctionalExpensesGrp>
        <TotalAmt>17258995</TotalAmt>
        <ProgramServicesAmt>13253790</ProgramServicesAmt>
        <ManagementAndGeneralAmt>3456205</ManagementAndGeneralAmt>
        <FundraisingAmt>549000</FundraisingAmt>
      </TotalFunctionalExpensesGrp>
      <CashNonInterestBearingGrp>
        <BOYAmt>109068</BOYAmt>
        <EOYAmt>81325</EOYAmt>
      </CashNonInterestBearingGrp>
      <PledgesAndGrantsReceivableGrp>
        <BOYAmt>1557582</BOYAmt>
        <EOYAmt>3256989</EOYAmt>
      </PledgesAndGrantsReceivableGrp>
      <AccountsReceivableGrp>
        <BOYAmt>40909</BOYAmt>
        <EOYAmt>116236</EOYAmt>
      </AccountsReceivableGrp>
      <PrepaidExpensesDefrdChargesGrp>
        <BOYAmt>77076</BOYAmt>
        <EOYAmt>91963</EOYAmt>
      </PrepaidExpensesDefrdChargesGrp>
      <LandBldgEquipCostOrOtherBssAmt>7934133</LandBldgEquipCostOrOtherBssAmt>
      <LandBldgEquipAccumDeprecAmt>6296898</LandBldgEquipAccumDeprecAmt>
      <LandBldgEquipBasisNetGrp>
        <BOYAmt>1961056</BOYAmt>
        <EOYAmt>1637235</EOYAmt>
      </LandBldgEquipBasisNetGrp>
      <InvestmentsPubTradedSecGrp>
        <BOYAmt>12070105</BOYAmt>
        <EOYAmt>10901701</EOYAmt>
      </InvestmentsPubTradedSecGrp>
      <InvestmentsOtherSecuritiesGrp>
        <EOYAmt>1408352</EOYAmt>
      </InvestmentsOtherSecuritiesGrp>
      <OtherAssetsTotalGrp>
        <BOYAmt>182885</BOYAmt>
        <EOYAmt>112517</EOYAmt>
      </OtherAssetsTotalGrp>
      <TotalAssetsGrp>
        <BOYAmt>15998681</BOYAmt>
        <EOYAmt>17606318</EOYAmt>
      </TotalAssetsGrp>
      <AccountsPayableAccrExpnssGrp>
        <BOYAmt>2828488</BOYAmt>
        <EOYAmt>6806079</EOYAmt>
      </AccountsPayableAccrExpnssGrp>
      <DeferredRevenueGrp>
        <BOYAmt>6439475</BOYAmt>
        <EOYAmt>6119044</EOYAmt>
      </DeferredRevenueGrp>
      <OtherLiabilitiesGrp>
        <BOYAmt>853826</BOYAmt>
        <EOYAmt>830300</EOYAmt>
      </OtherLiabilitiesGrp>
      <TotalLiabilitiesGrp>
        <BOYAmt>10121789</BOYAmt>
        <EOYAmt>13755423</EOYAmt>
      </TotalLiabilitiesGrp>
      <OrganizationFollowsSFAS117Ind>X</OrganizationFollowsSFAS117Ind>
      <UnrestrictedNetAssetsGrp>
        <BOYAmt>5876892</BOYAmt>
        <EOYAmt>3795475</EOYAmt>
      </UnrestrictedNetAssetsGrp>
      <TemporarilyRstrNetAssetsGrp>
        <EOYAmt>55420</EOYAmt>
      </TemporarilyRstrNetAssetsGrp>
      <TotalNetAssetsFundBalanceGrp>
        <BOYAmt>5876892</BOYAmt>
        <EOYAmt>3850895</EOYAmt>
      </TotalNetAssetsFundBalanceGrp>
      <TotLiabNetAssetsFundBalanceGrp>
        <BOYAmt>15998681</BOYAmt>
        <EOYAmt>17606318</EOYAmt>
      </TotLiabNetAssetsFundBalanceGrp>
      <ReconcilationRevenueExpnssAmt>-2025997</ReconcilationRevenueExpnssAmt>
      <OtherChangesInNetAssetsAmt>0</OtherChangesInNetAssetsAmt>
      <InfoInScheduleOPartXIIInd>X</InfoInScheduleOPartXIIInd>
      <MethodOfAccountingAccrualInd>X</MethodOfAccountingAccrualInd>
      <AccountantCompileOrReviewInd>0</AccountantCompileOrReviewInd>
      <FSAuditedInd>1</FSAuditedInd>
      <FSAuditedBasisGrp>
        <ConsolidatedBasisFinclStmtInd>X</ConsolidatedBasisFinclStmtInd>
      </FSAuditedBasisGrp>
      <AuditCommitteeInd>1</AuditCommitteeInd>
      <FederalGrantAuditRequiredInd>1</FederalGrantAuditRequiredInd>
      <FederalGrantAuditPerformedInd>1</FederalGrantAuditPerformedInd>
    </IRS990>
    <IRS990ScheduleA documentId="RetDoc1039100001">
      <PublicOrganization170Ind>X</PublicOrganization170Ind>
      <GiftsGrantsContriRcvd170Grp>
        <CurrentTaxYearMinus4YearsAmt>16526435</CurrentTaxYearMinus4YearsAmt>
        <CurrentTaxYearMinus3YearsAmt>12495973</CurrentTaxYearMinus3YearsAmt>
        <CurrentTaxYearMinus2YearsAmt>12253096</CurrentTaxYearMinus2YearsAmt>
        <CurrentTaxYearMinus1YearAmt>12110077</CurrentTaxYearMinus1YearAmt>
        <CurrentTaxYearAmt>13048070</CurrentTaxYearAmt>
        <TotalAmt>66433651</TotalAmt>
      </GiftsGrantsContriRcvd170Grp>
      <TotalCalendarYear170Grp>
        <CurrentTaxYearMinus4YearsAmt>16526435</CurrentTaxYearMinus4YearsAmt>
        <CurrentTaxYearMinus3YearsAmt>12495973</CurrentTaxYearMinus3YearsAmt>
        <CurrentTaxYearMinus2YearsAmt>12253096</CurrentTaxYearMinus2YearsAmt>
        <CurrentTaxYearMinus1YearAmt>12110077</CurrentTaxYearMinus1YearAmt>
        <CurrentTaxYearAmt>13048070</CurrentTaxYearAmt>
        <TotalAmt>66433651</TotalAmt>
      </TotalCalendarYear170Grp>
      <SubstantialContributorsTotAmt>20077506</SubstantialContributorsTotAmt>
      <PublicSupportTotal170Amt>46356145</PublicSupportTotal170Amt>
      <GrossInvestmentIncome170Grp>
        <CurrentTaxYearMinus4YearsAmt>115592</CurrentTaxYearMinus4YearsAmt>
        <CurrentTaxYearMinus3YearsAmt>52754</CurrentTaxYearMinus3YearsAmt>
        <CurrentTaxYearMinus2YearsAmt>68767</CurrentTaxYearMinus2YearsAmt>
        <CurrentTaxYearMinus1YearAmt>780822</CurrentTaxYearMinus1YearAmt>
        <CurrentTaxYearAmt>506380</CurrentTaxYearAmt>
        <TotalAmt>1524315</TotalAmt>
      </GrossInvestmentIncome170Grp>
      <OtherIncome170Grp>
        <CurrentTaxYearMinus4YearsAmt>68147</CurrentTaxYearMinus4YearsAmt>
        <CurrentTaxYearMinus3YearsAmt>108536</CurrentTaxYearMinus3YearsAmt>
        <CurrentTaxYearMinus2YearsAmt>233817</CurrentTaxYearMinus2YearsAmt>
        <CurrentTaxYearMinus1YearAmt>510879</CurrentTaxYearMinus1YearAmt>
        <CurrentTaxYearAmt>761128</CurrentTaxYearAmt>
        <TotalAmt>1682507</TotalAmt>
      </OtherIncome170Grp>
      <TotalSupportAmt>69640473</TotalSupportAmt>
      <PublicSupportCY170Pct>0.66560</PublicSupportCY170Pct>
      <PublicSupportPY170Pct>0.69810</PublicSupportPY170Pct>
      <ThirtyThrPctSuprtTestsCY170Ind>X</ThirtyThrPctSuprtTestsCY170Ind>
    </IRS990ScheduleA>
    <IRS990ScheduleB documentId="RetDoc1234500001">
      <ContributorInformationGrp>
        <ContributorNum>RESTRICTED</ContributorNum>
        <ContributorBusinessName>
          <BusinessNameLine1>RESTRICTED</BusinessNameLine1>
        </ContributorBusinessName>
        <ContributorUSAddress>
          <AddressLine1>RESTRICTED</AddressLine1>
          <AddressLine2>RESTRICTED</AddressLine2>
          <City>RESTRICTED</City>
          <State>RESTRICTED</State>
          <ZIPCode>RESTRICTED</ZIPCode>
        </ContributorUSAddress>
        <TotalContributionsAmt>RESTRICTED</TotalContributionsAmt>
      </ContributorInformationGrp>
    </IRS990ScheduleB>
    <IRS990ScheduleD documentId="RetDoc1040000001">
      <BuildingsGrp>
        <OtherCostOrOtherBasisAmt>8689</OtherCostOrOtherBasisAmt>
        <DepreciationAmt>4944</DepreciationAmt>
        <BookValueAmt>3745</BookValueAmt>
      </BuildingsGrp>
      <EquipmentGrp>
        <OtherCostOrOtherBasisAmt>7925444</OtherCostOrOtherBasisAmt>
        <DepreciationAmt>6291954</DepreciationAmt>
        <BookValueAmt>1633490</BookValueAmt>
      </EquipmentGrp>
      <TotalBookValueLandBuildingsAmt>1637235</TotalBookValueLandBuildingsAmt>
      <OtherSecuritiesGrp>
        <Desc>HEDGE FUNDS</Desc>
        <BookValueAmt>1408352</BookValueAmt>
        <MethodValuationCd>C</MethodValuationCd>
      </OtherSecuritiesGrp>
      <TotalBookValueSecuritiesAmt>1408352</TotalBookValueSecuritiesAmt>
      <OtherLiabilitiesOrgGrp>
        <Desc>PENSION CONTRIBUTION PAYABLE</Desc>
        <Amt>220478</Amt>
      </OtherLiabilitiesOrgGrp>
      <OtherLiabilitiesOrgGrp>
        <Desc>DEFERRED COMPENSATION PAYABLE</Desc>
        <Amt>609822</Amt>
      </OtherLiabilitiesOrgGrp>
      <TotalLiabilityAmt>830300</TotalLiabilityAmt>
      <FootnoteTextInd>X</FootnoteTextInd>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>PART X, LINE 2:</FormAndLineReferenceDesc>
        <ExplanationTxt>THE CORPORATION IS EXEMPT FROM FEDERAL AND STATE INCOME TAXES UNDER SECTION 501(C)(3) OF THE U.S. INTERNAL REVENUE CODE AND THE APPLICABLE STATE TAX STATUTES. FURTHER, THE CORPORATION HAS BEEN DETERMINED NOT TO BE A PRIVATE FOUNDATION UNDER SECTION 509(A) OF THE U.S. INTERNAL REVENUE CODE. MANAGEMENT HAS EVALUATED THE EFFECT OF THE ACCOUNTING PRINICPLES GENERALLY ACCEPTED IN THE UNITED STATES OF AMERICA ("GAAP") GUIDANCE RELATED TO ACCOUNTING FOR UNCERTAINTY IN INCOME TAXES. MANAGEMENT BELIEVES THAT THE CORPORATION AND FOUNDATION CONTINUE TO SATISFY THE REQUIREMENTS OF A TAX-EXEMPT ORGANIZATION AT DECEMBER 31, 2014. MANAGEMENT HAS EVALUATED ALL TAX POSITIONS THAT COULD HAVE A SIGNIFICANT EFFECT ON THE CONSOLIDATED FINANCIAL STATEMENTS AND DETERMINED THE CORPORATION AND FOUNDATION HAD NO UNCERTAIN INCOME TAX POSITIONS AT DECEMBER 31, 2014. THE ORGANIZATION BELIEVES IT IS NO LONGER SUBJECT TO INCOME TAX EXAMINATIONS FOR YEARS ENDED PRIOR TO DECEMBER 31, 2011.</ExplanationTxt>
      </SupplementalInformationDetail>
    </IRS990ScheduleD>
    <IRS990ScheduleG documentId="RetDoc1041200001">
      <PhoneSolicitationsInd>X</PhoneSolicitationsInd>
      <InPersonSolicitationsInd>X</InPersonSolicitationsInd>
      <AgrmtProfFundraisingActyInd>0</AgrmtProfFundraisingActyInd>
      <FundraiserActivityInfoGrp>
        <OrganizationBusinessName>
          <BusinessNameLine1Txt>CAIN GLOBAL</BusinessNameLine1Txt>
        </OrganizationBusinessName>
        <USAddress>
          <AddressLine1Txt>4208 SIX FORKS RD STE 1400</AddressLine1Txt>
          <CityNm>RALEIGH</CityNm>
          <StateAbbreviationCd>NC</StateAbbreviationCd>
          <ZIPCd>27609</ZIPCd>
        </USAddress>
        <ActivityTxt>PROFESSIONAL FUNDRAISER</ActivityTxt>
        <FundraiserControlOfFundsInd>0</FundraiserControlOfFundsInd>
        <GrossReceiptsAmt>0</GrossReceiptsAmt>
        <RetainedByContractorAmt>549000</RetainedByContractorAmt>
        <NetToOrganizationAmt>0</NetToOrganizationAmt>
      </FundraiserActivityInfoGrp>
      <TotalRetainedByContractorsAmt>549000</TotalRetainedByContractorsAmt>
    </IRS990ScheduleG>
    <IRS990ScheduleJ documentId="RetDoc1042400001">
      <CompensationCommitteeInd>X</CompensationCommitteeInd>
      <IndependentConsultantInd>X</IndependentConsultantInd>
      <Form990OfOtherOrganizationsInd>X</Form990OfOtherOrganizationsInd>
      <WrittenEmploymentContractInd>X</WrittenEmploymentContractInd>
      <CompensationSurveyInd>X</CompensationSurveyInd>
      <BoardOrCommitteeApprovalInd>X</BoardOrCommitteeApprovalInd>
      <SeverancePaymentInd>0</SeverancePaymentInd>
      <SupplementalNonqualRtrPlanInd>0</SupplementalNonqualRtrPlanInd>
      <EquityBasedCompArrngmInd>0</EquityBasedCompArrngmInd>
      <CompBasedOnRevenueOfFlngOrgInd>0</CompBasedOnRevenueOfFlngOrgInd>
      <CompBsdOnRevRelatedOrgsInd>0</CompBsdOnRevRelatedOrgsInd>
      <CompBsdNetEarnsFlngOrgInd>0</CompBsdNetEarnsFlngOrgInd>
      <CompBsdNetEarnsRltdOrgsInd>0</CompBsdNetEarnsRltdOrgsInd>
      <AnyNonFixedPaymentsInd>0</AnyNonFixedPaymentsInd>
      <InitialContractExceptionInd>0</InitialContractExceptionInd>
      <RltdOrgOfficerTrstKeyEmplGrp>
        <PersonNm>DR WILLIAM F GREENLEE</PersonNm>
        <TitleTxt>PRESIDENT &amp; CEO</TitleTxt>
        <BaseCompensationFilingOrgAmt>392885</BaseCompensationFilingOrgAmt>
        <CompensationBasedOnRltdOrgsAmt>0</CompensationBasedOnRltdOrgsAmt>
        <BonusFilingOrganizationAmount>115410</BonusFilingOrganizationAmount>
        <BonusRelatedOrganizationsAmt>0</BonusRelatedOrganizationsAmt>
        <OtherCompensationFilingOrgAmt>0</OtherCompensationFilingOrgAmt>
        <OtherCompensationRltdOrgsAmt>0</OtherCompensationRltdOrgsAmt>
        <DeferredCompensationFlngOrgAmt>21601</DeferredCompensationFlngOrgAmt>
        <DeferredCompRltdOrgsAmt>0</DeferredCompRltdOrgsAmt>
        <NontaxableBenefitsFilingOrgAmt>10713</NontaxableBenefitsFilingOrgAmt>
        <NontaxableBenefitsRltdOrgsAmt>0</NontaxableBenefitsRltdOrgsAmt>
        <TotalCompensationFilingOrgAmt>540609</TotalCompensationFilingOrgAmt>
        <TotalCompensationRltdOrgsAmt>0</TotalCompensationRltdOrgsAmt>
        <CompReportPrior990FilingOrgAmt>0</CompReportPrior990FilingOrgAmt>
        <CompReportPrior990RltdOrgsAmt>0</CompReportPrior990RltdOrgsAmt>
      </RltdOrgOfficerTrstKeyEmplGrp>
      <RltdOrgOfficerTrstKeyEmplGrp>
        <PersonNm>MS JAMIE WILKERSON</PersonNm>
        <TitleTxt>EXECUTIVE DIRECTOR OF FINANCE</TitleTxt>
        <BaseCompensationFilingOrgAmt>159040</BaseCompensationFilingOrgAmt>
        <CompensationBasedOnRltdOrgsAmt>0</CompensationBasedOnRltdOrgsAmt>
        <BonusFilingOrganizationAmount>29000</BonusFilingOrganizationAmount>
        <BonusRelatedOrganizationsAmt>0</BonusRelatedOrganizationsAmt>
        <OtherCompensationFilingOrgAmt>0</OtherCompensationFilingOrgAmt>
        <OtherCompensationRltdOrgsAmt>0</OtherCompensationRltdOrgsAmt>
        <DeferredCompensationFlngOrgAmt>9458</DeferredCompensationFlngOrgAmt>
        <DeferredCompRltdOrgsAmt>0</DeferredCompRltdOrgsAmt>
        <NontaxableBenefitsFilingOrgAmt>5455</NontaxableBenefitsFilingOrgAmt>
        <NontaxableBenefitsRltdOrgsAmt>0</NontaxableBenefitsRltdOrgsAmt>
        <TotalCompensationFilingOrgAmt>202953</TotalCompensationFilingOrgAmt>
        <TotalCompensationRltdOrgsAmt>0</TotalCompensationRltdOrgsAmt>
        <CompReportPrior990FilingOrgAmt>0</CompReportPrior990FilingOrgAmt>
        <CompReportPrior990RltdOrgsAmt>0</CompReportPrior990RltdOrgsAmt>
      </RltdOrgOfficerTrstKeyEmplGrp>
      <RltdOrgOfficerTrstKeyEmplGrp>
        <PersonNm>DR MELVIN ANDERSEN</PersonNm>
        <TitleTxt>CHIEF SCIENTIFIC OFFICER</TitleTxt>
        <BaseCompensationFilingOrgAmt>254402</BaseCompensationFilingOrgAmt>
        <CompensationBasedOnRltdOrgsAmt>0</CompensationBasedOnRltdOrgsAmt>
        <BonusFilingOrganizationAmount>62250</BonusFilingOrganizationAmount>
        <BonusRelatedOrganizationsAmt>0</BonusRelatedOrganizationsAmt>
        <OtherCompensationFilingOrgAmt>0</OtherCompensationFilingOrgAmt>
        <OtherCompensationRltdOrgsAmt>0</OtherCompensationRltdOrgsAmt>
        <DeferredCompensationFlngOrgAmt>14642</DeferredCompensationFlngOrgAmt>
        <DeferredCompRltdOrgsAmt>0</DeferredCompRltdOrgsAmt>
        <NontaxableBenefitsFilingOrgAmt>8774</NontaxableBenefitsFilingOrgAmt>
        <NontaxableBenefitsRltdOrgsAmt>0</NontaxableBenefitsRltdOrgsAmt>
        <TotalCompensationFilingOrgAmt>340068</TotalCompensationFilingOrgAmt>
        <TotalCompensationRltdOrgsAmt>0</TotalCompensationRltdOrgsAmt>
        <CompReportPrior990FilingOrgAmt>0</CompReportPrior990FilingOrgAmt>
        <CompReportPrior990RltdOrgsAmt>0</CompReportPrior990RltdOrgsAmt>
      </RltdOrgOfficerTrstKeyEmplGrp>
      <RltdOrgOfficerTrstKeyEmplGrp>
        <PersonNm>DR HARVEY CLEWELL III</PersonNm>
        <TitleTxt>DIRECTOR, CHHA</TitleTxt>
        <BaseCompensationFilingOrgAmt>180503</BaseCompensationFilingOrgAmt>
        <CompensationBasedOnRltdOrgsAmt>0</CompensationBasedOnRltdOrgsAmt>
        <BonusFilingOrganizationAmount>0</BonusFilingOrganizationAmount>
        <BonusRelatedOrganizationsAmt>0</BonusRelatedOrganizationsAmt>
        <OtherCompensationFilingOrgAmt>2417</OtherCompensationFilingOrgAmt>
        <OtherCompensationRltdOrgsAmt>0</OtherCompensationRltdOrgsAmt>
        <DeferredCompensationFlngOrgAmt>13522</DeferredCompensationFlngOrgAmt>
        <DeferredCompRltdOrgsAmt>0</DeferredCompRltdOrgsAmt>
        <NontaxableBenefitsFilingOrgAmt>9808</NontaxableBenefitsFilingOrgAmt>
        <NontaxableBenefitsRltdOrgsAmt>0</NontaxableBenefitsRltdOrgsAmt>
        <TotalCompensationFilingOrgAmt>206250</TotalCompensationFilingOrgAmt>
        <TotalCompensationRltdOrgsAmt>0</TotalCompensationRltdOrgsAmt>
        <CompReportPrior990FilingOrgAmt>0</CompReportPrior990FilingOrgAmt>
        <CompReportPrior990RltdOrgsAmt>0</CompReportPrior990RltdOrgsAmt>
      </RltdOrgOfficerTrstKeyEmplGrp>
      <RltdOrgOfficerTrstKeyEmplGrp>
        <PersonNm>DR MORRIS BUD NELSON</PersonNm>
        <TitleTxt>IN-HOUSE COUNSEL</TitleTxt>
        <BaseCompensationFilingOrgAmt>167721</BaseCompensationFilingOrgAmt>
        <CompensationBasedOnRltdOrgsAmt>0</CompensationBasedOnRltdOrgsAmt>
        <BonusFilingOrganizationAmount>0</BonusFilingOrganizationAmount>
        <BonusRelatedOrganizationsAmt>0</BonusRelatedOrganizationsAmt>
        <OtherCompensationFilingOrgAmt>0</OtherCompensationFilingOrgAmt>
        <OtherCompensationRltdOrgsAmt>0</OtherCompensationRltdOrgsAmt>
        <DeferredCompensationFlngOrgAmt>5950</DeferredCompensationFlngOrgAmt>
        <DeferredCompRltdOrgsAmt>0</DeferredCompRltdOrgsAmt>
        <NontaxableBenefitsFilingOrgAmt>10842</NontaxableBenefitsFilingOrgAmt>
        <NontaxableBenefitsRltdOrgsAmt>0</NontaxableBenefitsRltdOrgsAmt>
        <TotalCompensationFilingOrgAmt>184513</TotalCompensationFilingOrgAmt>
        <TotalCompensationRltdOrgsAmt>0</TotalCompensationRltdOrgsAmt>
        <CompReportPrior990FilingOrgAmt>0</CompReportPrior990FilingOrgAmt>
        <CompReportPrior990RltdOrgsAmt>0</CompReportPrior990RltdOrgsAmt>
      </RltdOrgOfficerTrstKeyEmplGrp>
      <RltdOrgOfficerTrstKeyEmplGrp>
        <PersonNm>DR DAROL DODD</PersonNm>
        <TitleTxt>SENIOR RESEARCH TOX.</TitleTxt>
        <BaseCompensationFilingOrgAmt>160010</BaseCompensationFilingOrgAmt>
        <CompensationBasedOnRltdOrgsAmt>0</CompensationBasedOnRltdOrgsAmt>
        <BonusFilingOrganizationAmount>0</BonusFilingOrganizationAmount>
        <BonusRelatedOrganizationsAmt>0</BonusRelatedOrganizationsAmt>
        <OtherCompensationFilingOrgAmt>0</OtherCompensationFilingOrgAmt>
        <OtherCompensationRltdOrgsAmt>0</OtherCompensationRltdOrgsAmt>
        <DeferredCompensationFlngOrgAmt>11687</DeferredCompensationFlngOrgAmt>
        <DeferredCompRltdOrgsAmt>0</DeferredCompRltdOrgsAmt>
        <NontaxableBenefitsFilingOrgAmt>7312</NontaxableBenefitsFilingOrgAmt>
        <NontaxableBenefitsRltdOrgsAmt>0</NontaxableBenefitsRltdOrgsAmt>
        <TotalCompensationFilingOrgAmt>179009</TotalCompensationFilingOrgAmt>
        <TotalCompensationRltdOrgsAmt>0</TotalCompensationRltdOrgsAmt>
        <CompReportPrior990FilingOrgAmt>0</CompReportPrior990FilingOrgAmt>
        <CompReportPrior990RltdOrgsAmt>0</CompReportPrior990RltdOrgsAmt>
      </RltdOrgOfficerTrstKeyEmplGrp>
      <RltdOrgOfficerTrstKeyEmplGrp>
        <PersonNm>DR EDWARD LECLUYSE</PersonNm>
        <TitleTxt>ASSOCIATE INVESTIGATOR</TitleTxt>
        <BaseCompensationFilingOrgAmt>146577</BaseCompensationFilingOrgAmt>
        <CompensationBasedOnRltdOrgsAmt>0</CompensationBasedOnRltdOrgsAmt>
        <BonusFilingOrganizationAmount>0</BonusFilingOrganizationAmount>
        <BonusRelatedOrganizationsAmt>0</BonusRelatedOrganizationsAmt>
        <OtherCompensationFilingOrgAmt>4924</OtherCompensationFilingOrgAmt>
        <OtherCompensationRltdOrgsAmt>0</OtherCompensationRltdOrgsAmt>
        <DeferredCompensationFlngOrgAmt>8097</DeferredCompensationFlngOrgAmt>
        <DeferredCompRltdOrgsAmt>0</DeferredCompRltdOrgsAmt>
        <NontaxableBenefitsFilingOrgAmt>8774</NontaxableBenefitsFilingOrgAmt>
        <NontaxableBenefitsRltdOrgsAmt>0</NontaxableBenefitsRltdOrgsAmt>
        <TotalCompensationFilingOrgAmt>168372</TotalCompensationFilingOrgAmt>
        <TotalCompensationRltdOrgsAmt>0</TotalCompensationRltdOrgsAmt>
        <CompReportPrior990FilingOrgAmt>0</CompReportPrior990FilingOrgAmt>
        <CompReportPrior990RltdOrgsAmt>0</CompReportPrior990RltdOrgsAmt>
      </RltdOrgOfficerTrstKeyEmplGrp>
    </IRS990ScheduleJ>
    <IRS990ScheduleL documentId="RetDoc1042800001">
      <BusTrInvolveInterestedPrsnGrp>
        <NameOfInterested>
          <BusinessName>
            <BusinessNameLine1Txt>ALEXANDRIA REAL ESTATE EQUITIES INC</BusinessNameLine1Txt>
          </BusinessName>
        </NameOfInterested>
        <RelationshipDescriptionTxt>BOARD MEMBER JOEL MARCUS IS THE CEO OF ALEXANDRIA REAL ESTATE EQUITIES</RelationshipDescriptionTxt>
        <TransactionAmt>1250798</TransactionAmt>
        <TransactionDesc>THE ORGANIZATION MADE A LEASE PAYMENT TO ALEXANDRIA REAL ESTATE EQUITIES. THE LEASE INCLUDES REPAIRS AND MAINTENANCE COSTS AND IS CHARGED TO THE ORGANIZATION AT OR LESS THAN FAIR MARKET VALUE.;LISTTOTAL 1039602</TransactionDesc>
        <SharingOfRevenuesInd>0</SharingOfRevenuesInd>
      </BusTrInvolveInterestedPrsnGrp>
    </IRS990ScheduleL>
    <IRS990ScheduleO documentId="RetDoc1044400001">
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>FORM 990, PART VI, SECTION B, LINE 11</FormAndLineReferenceDesc>
        <ExplanationTxt>A COPY OF THE FORM 990 WAS REVIEWED BY THE FINANCE COMMITTEE. AFTERWARDS THE FORM 990 WAS REVEIWED WITH THE BOARD PRIOR TO FILING.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>FORM 990, PART VI, SECTION B, LINE 12C</FormAndLineReferenceDesc>
        <ExplanationTxt>THE BOARD MAINTAINS A CONFLICT OF INTEREST POLICY WHICH IS SIGNED ON AN ANNUAL BASIS. IN THE COURSE OF MEETINGS OR ACTIVITIES, EVERYONE WILL DISCLOSE ANY INTERESTS IN A TRANSACTION OR DECISION WHERE HE/SHE (INCLUDING THEIR BUSINESS OR OTHER NON-PROFIT AFFILIATIONS, FAMILY AND/OR SIGNIFICANT OTHER, EMPLOYER OR CLOSE ASSOCIATES) MAY HAVE A CONFLICT. AFTER DISCLOSURE OF ANY POSSIBLE CONFLICT OF INTEREST, THE PERSON WILL BE ASKED TO LEAVE THE ROOM FOR THE DISCUSSION AND WILL NOT BE PERMITTED TO VOTE ON THE QUESTION.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>FORM 990, PART VI, SECTION B, LINE 15</FormAndLineReferenceDesc>
        <ExplanationTxt>HUMAN RESOURCES PREPARES MARKET ANALYSIS OF SALARY SURVEY AND OTHER DATA TO PROVIDE RECOMMENDATIONS TO THE INDEPENDENT COMPENSATION COMMITTEE, WHO REVIEWS THESE DATA ALONG WITH PERFORMANCE EVALUATIONS TO APPROVE ANY SALARY ADJUSTMENTS.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>FORM 990, PART VI, SECTION C, LINE 18</FormAndLineReferenceDesc>
        <ExplanationTxt>THE ORGANIZATION'S FORM 990 IS MADE AVAILABLE TO THE PUBLIC UPON REQUEST AND ON WWW.GUIDESTAR.ORG.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>FORM 990, PART VI, SECTION C, LINE 19</FormAndLineReferenceDesc>
        <ExplanationTxt>THE GOVERNING DOCUMENTS, CONFLICT OF INTEREST STATEMENT, AND FINANCIAL STATEMENTS ARE AVAILABLE TO THE PUBLIC UPON REQUEST.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>FORM 990, PART XII, LINE 2C:</FormAndLineReferenceDesc>
        <ExplanationTxt>THIS PROCESS HAS NOT CHANGED FROM THE PRIOR YEAR.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>FORM 990, PART III, LINE 4A:</FormAndLineReferenceDesc>
        <ExplanationTxt>IN JANUARY 2014, DR. PAUL B. WATKINS, INTERNATIONAL DRUG SAFETY EXPERT AND DIRECTOR OF THE HAMNER-UNIVERSITY OF NORTH CAROLINA INSTITUTE FOR DRUG SAFETY SCIENCES, RECEIVED AN AGILENT THOUGHT LEADER AWARD IN RECOGNITION OF HIS ONGOING WORK DEVELOPING INTEGRATED METHODS TO PREDICT DRUG-INDUCED LIVER INJURY (DILI). THE AWARD CONTINUES AGILENT'S SUPPORT OF THE RESEARCH HAMNER SCIENTISTS ARE CONDUCTING ON DRUG INDUCED LIVER INJURY. DR. WATKINS' STUDIES INVOLVE MOUSE GENETIC MODELS, PATIENTS WHO HAVE EXPERIENCED OR ARE EXPERIENCING DILI, AND PATIENT-SPECIFIC LIVER CULTURE MODELS DERIVED FROM STEM CELLS. ADDITIONALLY IN JANUARY 2014, STEMMING FROM AN ON-GOING COLLABORATION BETWEEN THE JOINT RESEARCH CENTRE'S EUROPEAN UNION REFERENCE LABORATORY FOR ALTERNATIVES TO ANIMAL TESTING (EURL ECVAM) AND THE HAMNER INSTITUTES FOR HEALTH SCIENCES (NC, USA), THE TWO ORGANIZATIONS PUBLISHED A LANDMARK REPORT, "TOXICITY PATHWAYS - FROM CONCEPTS TO APPLICATION IN CHEMICAL SAFETY ASSESSMENT." THE REPORT ADDRESSED KEY QUESTIONS, NAMELY: 1) WHAT CONSTITUTES A TOXICITY PATHWAY?; 2) HOW CAN WE USE TOXICITY PATHWAYS TO DEVELOP IN VITRO ASSAYS AND INTEGRATED TESTING STRATEGIES?; AND, 3) HOW CAN THE RESULTS FROM TOXICITY PATHWAY BASED TESTING SERVE HUMAN HEALTH RISK ASSESSMENTS? IN FEBRUARY 2014, THE HAMNER ANNOUNCED THAT OTSUKA PHARMACEUTICAL DEVELOPMENT &amp; COMMERCIALIZATION, INC. (OPDC) HAD AGREED TO BECOME THE NEWEST MEMBER OF THE DILI-SIM INITIATIVE. ESTABLISHED IN 2007, OPDC IS A PART OF THE JAPAN-BASED OTSUKA GROUP (OTSUKA) RESPONSIBLE FOR THE RESEARCH AND CLINICAL DEVELOPMENT OF HEALTHCARE PRODUCTS. OTSUKA BECAME THE TWELFTH MEMBER OF THE DILI-SIM CONSORTIUM, JOINING CURRENT MEMBERS AMGEN, ASTRAZENECA, BRISTOL-MYERS SQUIBB, ELI LILLY AND COMPANY, GILEAD, GLAXOSMITHKLINE, JANSSEN RESEARCH &amp; DEVELOPMENT, LLC, MERCK, MITSUBISHI TANABE PHARMA, PFIZER AND SANOFI. IN MARCH 2014, THE HAMNER ANNOUNCED THE LATEST RELEASE OF ITS FLAGSHIP DILI (DRUG-INDUCED LIVERY INJURY) PLATFORM - DILISYM SOFTWARE - VERSION 3A, AS WELL AS VERSION 2A OF ITS MITOSYM SOFTWARE, A MATHEMATICAL MODEL OF MITOCHONDRIAL FUNCTION. DILISYM AND MITOSYM SOFTWARE ARE DEVELOPED AND RELEASED AS PART OF THE DILI-SIM INITIATIVE (WWW.DILISYM.COM), AN EFFORT TO DEVELOP A MATHEMATICAL, MECHANISTIC MODEL OF DRUG-INDUCED LIVER INJURY CHAIRED BY DR. PAUL B. WATKINS. DILISYM V3A AND MITOSYM V2A WERE MADE AVAILABLE TO ALL DILI-SIM INITIATIVE INDUSTRY MEMBERS AS OF MARCH 6, 2014. A MID-YEAR UPDATE, DILISYM V3B, WAS MADE AVAILABLE IN AUGUST 2014. ALSO IN MARCH 2014, THE HAMNER ANNOUNCED THAT ABBVIE INC. HAD AGREED TO BECOME THE NEWEST MEMBER OF THE DILI-SIM INITIATIVE. FOUNDED IN 2013, ABBVIE IS A RESEARCH-BASED GLOBAL BIOPHARMACEUTICAL COMPANY WITH THE FOCUS AND CAPABILITIES TO ADDRESS SOME OF THE WORLD'S GREATEST HEALTH CHALLENGES. ABBVIE BECAME THE THIRTEENTH MEMBER OF THE DILI-SIM CONSORTIUM, JOINING CURRENT MEMBERS AMGEN, ASTRAZENECA, BRISTOL-MYERS SQUIBB, ELI LILLY AND COMPANY, GILEAD, GLAXOSMITHKLINE, JANSSEN RESEARCH &amp; DEVELOPMENT, LLC, MERCK, MITSUBISHI TANABE PHARMA, OTSUKA, PFIZER AND SANOFI. IN APRIL 2014, THE HAMNER ANNOUNCED THAT TAKEDA PHARMACEUTICALS INTERNATIONAL, INC. (TAKEDA) HAD AGREED TO BECOME THE NEWEST MEMBER OF THE DILI-SIM INITIATIVE. HAVING SUSTAINED A LONG CORPORATE HISTORY OF MORE THAN 230 YEARS, TAKEDA CONDUCTS ACTIVITIES ACCORDING TO THE CORPORATE MISSION TO "STRIVE TOWARDS BETTER HEALTH FOR PEOPLE WORLDWIDE THROUGH LEADING INNOVATION IN MEDICINE." TAKEDA BECAME THE FOURTEENTH MEMBER OF THE DILI-SIM CONSORTIUM, JOINING CURRENT MEMBERS ABBVIE, AMGEN, ASTRAZENECA, BRISTOL-MYERS SQUIBB, ELI LILLY AND COMPANY, GILEAD, GLAXOSMITHKLINE, JANSSEN RESEARCH &amp; DEVELOPMENT, LLC, MERCK, MITSUBISHI TANABE PHARMA, OTSUKA, PFIZER AND SANOFI. ADDITIONALLY IN APRIL 2014, THE HAMNER ANNOUNCED THAT ITS SCIENTISTS HAD BEEN RECOGNIZED WITH SIX AWARDS FROM THE SOCIETY OF TOXICOLOGY (SOT), A PROFESSIONAL ORGANIZATION COMMITTED TO CREATING A SAFER AND HEALTHIER WORLD BY ADVANCING THE SCIENCE OF TOXICOLOGY, AT THEIR 53RD ANNUAL MEETING THAT WAS HELD MARCH 23-27 IN PHOENIX, ARIZONA. THE AWARD HONORS FOLLOW AN IMPRESSIVE PRESENCE AT THE MEETING THAT CONSISTED OF OVER 40 PRESENTATIONS BY HAMNER SCIENTISTS. IN TOTAL, EIGHT INSTITUTE SCIENTISTS WERE RECOGNIZED FOR THEIR CONTRIBUTIONS TO VARIOUS TOP ABSTRACTS, POSTERS, AND PAPERS ENCOMPASSING WORK PERFORMED OVER THE LAST YEAR. PARTICULARLY NOTEWORTHY WERE THE ACCOMPLISHMENTS OF DRS. RACHEL CHURCH AND HUALI WU, POSTDOCTORAL FELLOWS WHO EACH RECEIVED NAMED AWARDS AND OTHER HONORS AT THIS YEAR'S MEETING. ADDITIONALLY, DR. QIANG ZHANG, DIRECTOR, CENTER FOR DOSE RESPONSE MODELING AT THE HAMNER, WAS RECOGNIZED FOR HAVING A TOP 10 BEST PAPER OF 2013 IN THE BIOLOGICAL MODELING SPECIALTY SECTION. FOR A COMPLETE LIST OF THE HAMNER'S AWARDS AT SOT, PLEASE VISIT: HTTP://WWW.THEHAMNER.ORG/NEWS-EVENTS/ENTRY/HAMNER-AWARDS-AT-THE-2014- SOCIETY-OF-TOXICOLOGY-ANNUAL-MEETING. IN MAY 2014, IN ALIGNMENT WITH ITS VISION AND COMMITMENT TO TRANSLATIONAL LIFE SCIENCES TRAINING, THE HAMNER INSTRUCTED A THREE-DAY SHORT COURSE FOR OVER 20 PARTICIPANTS FROM MAY 20-22 THAT COVERED THE APPLICATION OF COMPUTATIONAL MODELING PARADIGMS TO HUMAN HEALTH ASSESSMENTS. JOINTLY ORGANIZED BY THE HAMNER'S INSTITUTE FOR CHEMICAL SAFETY SCIENCES AND THE HOST CENTER FOR INTEGRATIVE TOXICOLOGY AT MICHIGAN STATE UNIVERSITY, THE COURSE FEATURED COMPREHENSIVE LECTURES AND EXTENSIVE HANDS-ON COMPUTER MODELING PRACTICE, AND WAS DESIGNED TO SERVE A VARIETY OF SCIENTIFIC COMMUNITIES, INCLUDING INDUSTRIAL, PHARMACEUTICAL AND REGULATORY SCIENTISTS, TOXICOLOGISTS AND RESEARCH SCIENTISTS, AND INDIVIDUALS INTERESTED IN PROMOTING THE USE OF ALTERNATIVES TO LIVE ANIMAL TESTING. IN SEPTEMBER 2014, IN ALIGNMENT WITH ITS VISION AND COMMITMENT TO TRANSLATIONAL LIFE SCIENCES TRAINING, THE HAMNER INSTRUCTED A ONE WEEK COURSE FOR OVER 25 PARTICIPANTS FROM MONDAY, SEPT. 22 THROUGH FRIDAY, SEPT. 26 THAT COVERED THE APPLICATION OF COMPUTATIONAL MODELING PARADIGMS TO HUMAN HEALTH ASSESSMENTS. THE COURSE FEATURED COMPREHENSIVE LECTURES AND EXTENSIVE HANDS-ON COMPUTER MODELING PRACTICE, AND WAS DESIGNED TO SERVE A VARIETY OF SCIENTIFIC COMMUNITIES, INCLUDING INDUSTRIAL, PHARMACEUTICAL AND REGULATORY SCIENTISTS, TOXICOLOGISTS AND RESEARCH SCIENTISTS, AND INDIVIDUALS INTERESTED IN PROMOTING THE USE OF ALTERNATIVES TO LIVE ANIMAL TESTING. ALSO IN SEPTEMBER 2014, RESEARCHERS AT THE UNC ESHELMAN SCHOOL OF PHARMACY, USING THE HAMNER'S DILISYM SOFTWARE, PUBLISHED A LANDMARK PAPER IN THE JOURNAL CLINICAL PHARMACOLOGY AND THERAPEUTICS THAT THEY BELIEVE SOLVES THE MYSTERY OF WHY A DIABETES DRUG INTRODUCED IN 1997 CAUSED LIVER FAILURE AND DEATH IN SIXTY-THREE PATIENTS. THEIR DISCOVERY MAKES IT LIKELY THAT SIMILAR DRUG-RELATED DEATHS CAN BE PREVENTED IN THE FUTURE. HAMNER INVESTIGATORS WERE CO-AUTHORS ON THE PUBLICATION. IN OCTOBER 2014, ENVIRON, AN INTERNATIONAL ENVIRONMENTAL, HEALTH, SAFETY AND SUSTAINABILITY CONSULTANCY, ANNOUNCED THAT DR. HARVEY CLEWELL III, DIRECTOR OF THE HAMNER'S CENTER FOR HUMAN HEALTH ASSESSMENT, HAD REJOINED THE FIRM AS A PRINCIPAL CONSULTANT AND WILL WORK CLOSELY WITH SENIOR PROFESSIONALS IN ENVIRON'S HEALTH SCIENCES PRACTICE. DR. CLEWELL WILL ALSO CONTINUE TO SERVE IN HIS CURRENT POSITION AT THE HAMNER INSTITUTES FOR HEALTH SCIENCES (THE HAMNER) IN RESEARCH TRIANGLE PARK, NORTH CAROLINA. THIS NEW FORMAL COLLABORATIVE RELATIONSHIP BETWEEN ENVIRON AND THE HAMNER CONTINUES A SUCCESSFUL HISTORY OF PARTNERING ON VARIOUS RESEARCH AND ASSESSMENT PROJECTS. IN FACT, DR. CLEWELL SERVED AS A PRINCIPAL AT ENVIRON FOR 12 YEARS BEFORE JOINING THE HAMNER IN 2005. THIS RELATIONSHIP ALSO BRINGS INCREASED SCIENTIFIC EXPERTISE TO ENVIRON THROUGH THE HAMNER'S PARTNERSHIPS WITH ACADEMIA, INDUSTRY AND GOVERNMENT, AS WELL AS THEIR TRANSLATION OF INNOVATIVE LIFE SCIENCES AND BIOMEDICAL RESEARCH THROUGH THE DEVELOPMENT AND INTEGRATION OF CUTTING-EDGE SAFETY SCIENCE PREDICTIVE TECHNOLOGIES. ALSO IN OCTOBER 2014, HAMNER ICSS SCIENTISTS CO-HOSTED THE FIRST WORKSHOP AND LABORATORY-BASED TRAINING COURSE FOR SYSTEMS TOXICOLOGY IN CHINA. THE INTERNATIONAL WORKSHOP, ENTITLED "SYSTEMS TOXICOLOGY: DEVELOPING MECHANISTIC UNDERSTANDING OF TOXICITY PATHWAYS AND ESTABLISHING PREDICTIVE TOXICOLOGY FOR USE IN RISK ASSESSMENTS," BROUGHT TOGETHER GLOBAL EXPERTS FROM INDUSTRY, ACADEMIA, AND GOVERNMENT TO DISCUSS A WIDE RANGE OF TOPICS AND SHARE THEIR OWN EXPERIENCES DEVELOPING AND IMPLEMENTING SYSTEMS TOXICOLOGY APPROACHES. IN ADDITION TO THE HAMNER, LEADING SCIENTISTS FROM AGILENT TECHNOLOGIES, CELLULAR DYNAMICS INTERNATIONAL, ACEA BIOSCIENCES, STRAND LIFE SCIENCES, STEMINA BIOMARKER DISCOVERY, AND THE U.S. NIH NCATS, GATHERED AT THE AGILENT CENTER OF EXCELLENCE IN BEIJING TO PROVIDE PARTICIPANTS THE OPPORTUNITY TO LEARN THE BASIS AND APPLICATION OF VARIOUS SYSTEMS TOXICOLOGY DISCIPLINES.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>FORM 990, PART III, LINE 4A:</FormAndLineReferenceDesc>
        <ExplanationTxt>IN NOVEMBER 2014, HAMNER-UNC INSTITUTE FOR DRUG SAFETY SCIENCES DIRECTOR DR. PAUL B. WATKINS WAS AWARDED THE 2015 RAWLS-PALMER PROGRESS IN MEDICINE AWARD FROM THE AMERICAN INSTITUTE OF CLINICAL PHARMACOLOGY AND THERAPEUTICS FOR MULTIPLE CONTRIBUTIONS TO THE FIELD OF CLINICAL PHARMACOLOGY. ESTABLISHED IN 1978, THE RAWLS-PALMER AWARD IS GIVEN TO THOSE WHO CONTRIBUTE MEANINGFUL RESEARCH THAT IMPROVES PATIENT CARE. WATKINS HAS BEEN INVITED TO GIVE MORE THAN 180 TALKS WORLDWIDE REGARDING HIS RESEARCH ON ENZYMES THAT METABOLIZE MEDICATION, GRAPEFRUIT-DRUG INTERACTIONS, AND DRUG-INDUCED LIVER INJURY. WITH MORE THAN 170 ORIGINAL MANUSCRIPTS AND THIRTY BOOK CHAPTERS PUBLISHED, WATKINS' RESEARCH HAS BEEN CITED MORE THAN 14,000 TIMES. WATKINS IS ONE OF SEVEN PEOPLE TO WIN A 2015 ASCPT AWARD AND WILL RECEIVE OFFICIAL RECOGNITION DURING THE 2015 ANNUAL ASCPT MEETING IN MARCH. THE HAMNER INSTITUTES FOR HEALTH SCIENCES AND THE EUROPEAN INNOVATIVE MEDICINES INITIATIVE (IMI) CO-SPONSORED A 2012 WORKSHOP IN BOSTON ON BEST PRACTICES IN CLINICAL LIVER SAFETY ASSESSMENT THAT INCLUDED ACADEMIC AND INDUSTRY LEADERS AND ALSO REGULATORS FROM FDA, HEALTH CANADA, EUROPEAN MEDICINES AGENCY, AND REGULATORS FROM JAPAN AND CHINA. THE OUTCOME OF THIS WORKSHOP WAS SIX WHITE PAPERS TO BE PUBLISHED TOGETHER IN DECEMBER 2014 IN THE JOURNAL "DRUG SAFETY". TO ACCESS THIS REPORT, PLEASE CLICK THE LINK BELOW: HTTP://LINK.SPRINGER.COM/JOURNAL/40264/37/1/SUPPL/PAGE/1.</ExplanationTxt>
      </SupplementalInformationDetail>
    </IRS990ScheduleO>
    <IRS990ScheduleR documentId="RetDoc1043400001">
      <IdRelatedTaxExemptOrgGrp>
        <DisregardedEntityName>
          <BusinessNameLine1Txt>HEALTH RESEARCH &amp; EDUCATION FOUNDATION</BusinessNameLine1Txt>
        </DisregardedEntityName>
        <USAddress>
          <AddressLine1Txt>6 DAVIS DRIVE</AddressLine1Txt>
          <CityNm>RESEARCH TRIANGLE PARK</CityNm>
          <StateAbbreviationCd>NC</StateAbbreviationCd>
          <ZIPCd>27709</ZIPCd>
        </USAddress>
        <EIN>311753977</EIN>
        <PrimaryActivitiesTxt>HEALTH EDUCATION AND RESEARCH</PrimaryActivitiesTxt>
        <LegalDomicileStateCd>NC</LegalDomicileStateCd>
        <ExemptCodeSectionTxt>501(C)(3)</ExemptCodeSectionTxt>
        <PublicCharityStatusTxt>PF</PublicCharityStatusTxt>
        <DirectControllingEntityName>
          <BusinessNameLine1Txt>THE HAMNER INSTITUTES</BusinessNameLine1Txt>
        </DirectControllingEntityName>
        <ControlledOrganizationInd>1</ControlledOrganizationInd>
      </IdRelatedTaxExemptOrgGrp>
      <ReceiptOfIntAnntsRntsRyltsInd>0</ReceiptOfIntAnntsRntsRyltsInd>
      <GiftGrntOrCapContriToOthOrgInd>0</GiftGrntOrCapContriToOthOrgInd>
      <GiftGrntCapContriFromOthOrgInd>0</GiftGrntCapContriFromOthOrgInd>
      <LoansOrGuaranteesToOtherOrgInd>0</LoansOrGuaranteesToOtherOrgInd>
      <LoansOrGuaranteesFromOthOrgInd>0</LoansOrGuaranteesFromOthOrgInd>
      <DivRelatedOrganizationInd>0</DivRelatedOrganizationInd>
      <AssetSaleToOtherOrgInd>0</AssetSaleToOtherOrgInd>
      <AssetPurchaseFromOtherOrgInd>0</AssetPurchaseFromOtherOrgInd>
      <AssetExchangeInd>0</AssetExchangeInd>
      <RentalOfFacilitiesToOthOrgInd>0</RentalOfFacilitiesToOthOrgInd>
      <RentalOfFcltsFromOthOrgInd>0</RentalOfFcltsFromOthOrgInd>
      <PerformOfServicesForOthOrgInd>0</PerformOfServicesForOthOrgInd>
      <PerformOfServicesByOtherOrgInd>0</PerformOfServicesByOtherOrgInd>
      <SharingOfFacilitiesInd>0</SharingOfFacilitiesInd>
      <PaidEmployeesSharingInd>0</PaidEmployeesSharingInd>
      <ReimbursementPaidToOtherOrgInd>0</ReimbursementPaidToOtherOrgInd>
      <ReimbursementPaidByOtherOrgInd>1</ReimbursementPaidByOtherOrgInd>
      <TransferToOtherOrgInd>0</TransferToOtherOrgInd>
      <TransferFromOtherOrgInd>0</TransferFromOtherOrgInd>
    </IRS990ScheduleR>
  </ReturnData>
</Return>